Micron Biomedical

Featured

Micron Biomedical Celebrates the Grand Opening of Its Commercial-Scale Manufacturing Site in Georgia

May 21, 2026

Micron Biomedical Named to Fast Company’s 2026 List of World’s Most Innovative Companies for Addressing the Most Significant Bottlenecks in How Medicine is Made, Distributed and Administered

March 26, 2026

Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation Rotavirus Vaccine Delivered via Dissolvable Microarray Technology

June 16, 2025

Endpoints News: “Micron Biomedical has started 2025 on a positive note”

January 16, 2025

BBC Spotlights “Extremely Promising” Micron Biomedical Data Publication in The Lancet

May 1, 2024

Newsweek Spotlights Micron Technology as Part of Bill Gates’Plan to Change Vaccines

January 18, 2024

World Economic Forum Spotlights Micron’s Dissolvable Microneedles and the Opportunity to Increase Vaccine Uptake

November 23, 2023

Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of Needle-Free Vaccines and to Help Eradicate Measles

November 16, 2023

Reuters Spotlights Micron’s Progress Toward Mass Production of Its Proprietary Microarray Technology

November 16, 2023

Atlanta News First Spotlights Micron Biomedical’s “Game Changing Technology”

November 16, 2023

Micron Biomedical Spotlighted by GAVI, the Vaccine Alliance

July 6, 2023

Startups’ Patch Technologies Could Extend Reach of Vaccines

June 1, 2023